Keyphrases
Prostate Cancer
100%
Chemotherapy
100%
Angiogenesis Inhibition
100%
Cancer History
100%
Hormone-sensitive Prostate Cancer
100%
Leukemia
50%
Bevacizumab
50%
Clinical Benefit
50%
Clinical Experience
50%
Early Disease
50%
Angiogenesis Inhibitors
50%
Agent Behavior
50%
Anti-angiogenic Strategies
50%
Medicine and Dentistry
Prostate Cancer
100%
Antiangiogenic Activity
100%
Castration Resistant Prostate Cancer
100%
Malignant Neoplasm
50%
Cancer
50%
Antiangiogenic Therapy
50%
Angiogenesis Inhibitor
50%
Leukemia
50%
Bevacizumab
50%
Diseases
50%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Prostate Cancer
100%
Castration Resistant Prostate Cancer
100%
Leukemia
50%
Antiangiogenic
50%
Malignant Neoplasm
50%
Bevacizumab
50%
Angiogenesis Inhibitor
50%
Diseases
50%
Nursing and Health Professions
Castration Resistant Prostate Cancer
100%
Prostate Cancer
100%
Malignant Neoplasm
50%
Leukemia
50%
Antiangiogenic Therapy
50%
Bevacizumab
50%
Angiogenesis Inhibitor
50%
Diseases
50%